Currently, synthetic small molecule compounds and natural plant extracts, such as RSL3, terpenoids, and phenols, have been developed to induce ferroptosis for cancer treatment by directly inhibiting GPX4, but these experimental drugs typically exhibit severe cytotoxicity and have unclear pharmacokinetic profiles [47–49]. Here, GPX4 is linked to cancer.